daprodustat | Daprodustat for the Treatment of Anemia in Patients …

Keyword	CPC	PCC	Volume	Score	Length of keyword
daprodustat	1.85	0.6	1653	78	11

Keyword	CPC	PCC	Volume	Score
daprodustat	1.62	0.2	9906	2
daprodustat gsk	1.05	0.6	7358	63
daprodustat fda	0.28	0.9	2159	9
daprodustat ema	0.11	1	3471	69
daprodustat fda approval	1.31	0.4	8438	28
daprodustat price	1.26	0.4	1215	16
daprodustat solubility	0.93	0.2	2523	100
daprodustat synthesis	0.35	0.5	9038	67
daprodustat fda label	1.82	0.1	8030	23
daprodustat approval	1.53	0.1	9225	56
daprodustat label	1.15	0.9	3292	70
daprodustat mechanism of action	0.1	0.9	3408	97
daprodustat package insert	1.04	0.9	1535	50
daprodustat structure	1.84	0.2	9422	27
daprodustat impurities	1.98	0.7	4603	57

Search Results related to daprodustat on Search Engine

Daprodustat for the Treatment of Anemia in Patients …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2113380

WEBNov 5, 2021 · Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. In patients with chronic kidney disease (CKD) … Author: Ajay K Singh, Kevin Carroll, John J V McMurray, Scott Solomon, Vivekanand Jha, Kirsten L Johansen, R... Publish Year: 2021

Author: Ajay K Singh, Kevin Carroll, John J V McMurray, Scott Solomon, Vivekanand Jha, Kirsten L Johansen, R...
Publish Year: 2021

DA: 18 PA: 68 MOZ Rank: 74

FDA Approves First Oral Treatment for Anemia Caused by …
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-anemia-caused-chronic-kidney-disease-adults-dialysis

WEBFeb 1, 2023 · Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood …

DA: 88 PA: 56 MOZ Rank: 15

Jesduvroq (daprodustat) approved by US FDA for anemia of …
gsk.com

https://us.gsk.com/en-us/media/press-releases/jesduvroq-daprodustat-approved-by-us-fda-for-anemia-of-chronic-kidney-disease-in-adults-on-dialysis/

WEBFeb 1, 2023 · Jesduvroq is the first oral HIF-PHI for the treatment of anemia of chronic kidney disease (CKD) in adults on dialysis. It is the only oral option for patients with …

DA: 2 PA: 47 MOZ Rank: 98

Daprodustat Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/daprodustat.html

WEBSep 28, 2023 · Daprodustat is a medication used to treat anemia caused by chronic kidney disease in adults on dialysis. Learn about its dosage, interactions, precautions, and …

DA: 91 PA: 2 MOZ Rank: 58

Daprodustat: Uses, Interactions, Mechanism of Action
drugbank.com

https://go.drugbank.com/drugs/DB11682

WEB210 rows · Drug created at October 20, 2016 20:39 / Updated at February 08, 2023 21:47. Daprodustat is a small-molecule hypoxia-inducible factor prolyl hydroxylase inhibitor …

DA: 70 PA: 49 MOZ Rank: 23

Daprodustat for the Treatment of Anemia in Patients …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2113379

WEBNov 5, 2021 · Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors (PHIs) are investigational agents that may offer an alternative oral treatment option for anemia associated with CKD. 7 By stabilizing...

DA: 72 PA: 5 MOZ Rank: 83

Daprodustat - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Daprodustat

DA: 97 PA: 70 MOZ Rank: 55

Jesduvroq (daprodustat) approved by US FDA for anaemia of …
gsk.com

https://www.gsk.com/en-gb/media/press-releases/jesduvroq-daprodustat-approved-by-us-fda-for-anaemia-of-chronic-kidney-disease-in-adults-on-dialysis/

WEBJesduvroq is the first oral HIF-PHI for the treatment of anaemia of chronic kidney disease (CKD) in adults on dialysis. It is the only oral medicine for anaemia of CKD in the US, …

DA: 77 PA: 37 MOZ Rank: 8

Jesduvroq: Uses, Dosage, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/jesduvroq.html

WEBAug 23, 2023 · Jesduvroq (daprodustat) tablets are used to treat anemia (low red blood cells) that is caused by chronic kidney disease (CKD) in patients who have been on …

DA: 45 PA: 59 MOZ Rank: 97